167 related articles for article (PubMed ID: 38404999)
1. Nomogram for predicting prognosis and identifying chemotherapy beneficiaries for completely resected stage I invasive mucinous lung adenocarcinoma.
He H; Zeng X; Zhang Q; Hu W; Huang R; Zhao H; Sun S; Lin R; Yue P; Han B; Ma M; Chen C
Transl Lung Cancer Res; 2024 Jan; 13(1):95-111. PubMed ID: 38404999
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.
Qian J; Xu J; Wang S; Qian F; Yang W; Zhang B; Zhang Y; Nie W; Lou Y; Lu J; Zhang X; Zhang W; Chu T; Zhong H; Fang W; Zhao H; Han B
Ann Surg Oncol; 2019 Aug; 26(8):2392-2400. PubMed ID: 31011907
[TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study.
Yu S; You C; Yan R; Chen H; Chen C; Xu S; Gonzalez M; Chen R; Kang M; Chen S
Transl Lung Cancer Res; 2022 Nov; 11(11):2275-2288. PubMed ID: 36519020
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
[TBL] [Abstract][Full Text] [Related]
6. Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma.
Xie D; Wang TT; Huang SJ; Deng JJ; Ren YJ; Yang Y; Wu JQ; Zhang L; Fei K; Sun XW; She YL; Chen C
Transl Lung Cancer Res; 2020 Aug; 9(4):1112-1123. PubMed ID: 32953490
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
[TBL] [Abstract][Full Text] [Related]
8. A risk classification system predicting the cancer-specific survival for postoperative stage IB non-small-cell lung cancer patients without lymphovascular and visceral pleural invasion.
Tu Z; Li C; Tian T; Chen Q
Lung Cancer; 2021 Nov; 161():114-121. PubMed ID: 34583219
[TBL] [Abstract][Full Text] [Related]
9. A validated model to predict spread through air space in lung adenocarcinoma.
Zheng Y; Han X; Li H; Luo Q; Ding C; Zhang K; Fan J; Zeng W; Shi H
J Thorac Dis; 2024 Apr; 16(4):2296-2313. PubMed ID: 38738222
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.
Ueda D; Ito M; Tsutani Y; Giménez-Capitán A; Román-Lladó R; Pérez-Rosado A; Aguado C; Kushitani K; Miyata Y; Arihiro K; Molina-Vila MA; Rosell R; Takeshima Y; Okada M
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3709-3718. PubMed ID: 33796913
[TBL] [Abstract][Full Text] [Related]
11. Prognostic assessment of lung adenocarcinoma patients with early-staging diseases: a nomogram based on coagulation-related factors.
Wu LL; Lin WK; Qian JY; Ma SS; Li MJ; Li K; Li ZX; Lan G; Xie D
Eur J Cardiothorac Surg; 2023 Nov; 64(5):. PubMed ID: 37699000
[TBL] [Abstract][Full Text] [Related]
12. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
[TBL] [Abstract][Full Text] [Related]
13. [Construction of a Prognostic Prediction Model of Patients with Pathologic N0
in Resected Invasive Mucinous Adenocarcinoma of the Lung].
Wang Z; He J; Shen H; Chen X; Lin C; Yu H; Gao J; He X; Shen W
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):47-55. PubMed ID: 38296625
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of postoperative longitudinal change of serum carcinoembryonic antigen level in patients with stage I lung adenocarcinoma completely resected by single-port video-assisted thoracic surgery: a retrospective study.
Chen H; Jiang Y; Jia K; Zhang K; Matsuura N; Jeong JY; Su B; Zhou X
Transl Lung Cancer Res; 2021 Oct; 10(10):3983-3994. PubMed ID: 34858786
[TBL] [Abstract][Full Text] [Related]
15. Nomogram Using CT Radiomics Features for Differentiation of Pneumonia-Type Invasive Mucinous Adenocarcinoma and Pneumonia: Multicenter Development and External Validation Study.
Yu X; Zhang S; Xu J; Huang Y; Luo H; Huang C; Nie P; Deng Y; Mao N; Zhang R; Gao L; Li S; Kang B; Wang X
AJR Am J Roentgenol; 2023 Feb; 220(2):224-234. PubMed ID: 36102726
[No Abstract] [Full Text] [Related]
16. Multivariate analysis based on the maximum standard unit value of
Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S
Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049
[TBL] [Abstract][Full Text] [Related]
17. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.
Zhang Z; Xie S; Cai W; Hong ZN; Yang C; Lin Y; Zhu J; Lin Z; Christoph DC; Bohnenberger H; Kepka L; Brueckl WM; Van Houtte P; Kang M; Lin J
Transl Lung Cancer Res; 2022 Jan; 11(1):75-86. PubMed ID: 35242629
[TBL] [Abstract][Full Text] [Related]
18. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma.
Ren H; Wu CR; Aimaiti S; Wang CF
Oncol Lett; 2020 Jun; 19(6):4093-4105. PubMed ID: 32382348
[TBL] [Abstract][Full Text] [Related]
20. A Nomogram Model to Predict Prognosis of Patients With Genitourinary Sarcoma.
Li L; Liang J; Song T; Yin S; Zeng J; Zhong Q; Feng X; Jia Z; Fan Y; Wang X; Lin T
Front Oncol; 2021; 11():656325. PubMed ID: 33937065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
